Consultation outcome

Statutory scheme to control costs of branded health service medicines

• From: Department of Health and Social Care
• Published: 7 August 2018
• Last updated: 3 December 2018 — See all updates

This was published under the 2016 to 2019 May Conservative government

This consultation has concluded

Read the full outcome

Proposed changes to the statutory scheme to control the costs of branded health service medicines: consultation response

PDF, 301 KB, 45 pages

Impact assessment: 2018 statutory scheme – branded medicines pricing

PDF, 558 KB, 46 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of outcome

The government will set a revised payment percentage from 1 January 2019, alongside the other changes proposed. These are described in the response document. There have been changes to the impact assessment in response to consultation feedback.

The finalised regulations and explanatory memorandum have been published.

---

Original consultation

Summary

This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded health medicines.

This consultation ran from
1pm on 5 October 2018 to 11:59pm on 19 October 2018

Consultation description

In August 2018 the department consulted on proposed changes to the Branded Health Service Medicines (Costs) Regulations 2018. Some respondents asked for more information about:

• the expected 2018 baseline for forecast relevant sales and allowed relevant sales
• the calculation of the payment percentages for 2019 to 2021

The clarification note provides additional information about these issues to help respondents understand how the department calculated the proposed payment percentages.

Further comments are being invited on the proposed payment percentages and the methodology used in determining the payment percentages. Full details of how to submit further comments are provided in the clarification note.

Documents

Changes to the statutory scheme to control the costs of branded health service medicines: clarification note

PDF, 99.1 KB, 6 pages

Proposed changes to the statutory scheme to control the costs of branded health service medicines: consultation document

PDF, 225 KB, 28 pages

2018 Statutory Scheme – Branded Medicines Pricing: impact assessment

PDF, 1.36 MB, 38 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 7 August 2018
Last updated 3 December 2018 + show all updates

1. 3 December 2018

   Consultation response and final impact assessment published.

2. 5 October 2018

   Added clarification note to consultation page. This provides more information to help respondents understand how the department calculated the proposed payment percentages and invites further comments by 19 October 2018.

3. 7 August 2018

   First published.